In vivo Experience With NRT to Increase Adherence and Smoking Abstinence Among Individuals in the Criminal Legal System: Study Protocol for a Randomized Clinical Trial

Elizabeth S Hawes, Sofía Mildrum Chana, Alexandra Faust, Julianne C Baker, Peter S Hendricks, Andres Azuero, Adrienne C Lahti, Matthew J Carpenter, Karen L Cropsey, Elizabeth S Hawes, Sofía Mildrum Chana, Alexandra Faust, Julianne C Baker, Peter S Hendricks, Andres Azuero, Adrienne C Lahti, Matthew J Carpenter, Karen L Cropsey

Abstract

Background: While tobacco use among individuals involved in the criminal legal system remains 3-4 times higher than the general population, few interventions have been targeted for this population to aid in smoking cessation. Nicotine replacement therapy (NRT) is a relatively effective and accessible smoking cessation aid; however, individuals frequently stop use of NRT early due to side effects and misperceptions about the products. The present study aims to address low medication adherence by examining the efficacy of an "in vivo" NRT sampling experience in individuals under community criminal legal supervision.

Methods: Following recruitment through community legal outlets, participants (N = 517) are randomized to either an "in vivo NRT sampling" group or a standard smoking cessation behavioral counseling group. The in vivo group uses NRT in session and discusses perceptions and experiences of using NRT in real time while the standard smoking cessation counseling group receives four sessions of standard behavioral smoking cessation counseling. Both groups receive four intervention sessions and 12 weeks of NRT following the intervention. The 6-month post-intervention primary outcome measures are smoking point-prevalence abstinence and medication adherence.

Conclusion: This is a novel smoking cessation intervention specifically aimed at increasing NRT adherence and smoking cessation among those involved in the criminal legal system, a group of individuals with high smoking rates and low rates of pharmacotherapy use. If proven effective, the present treatment could be a novel intervention to implement in criminal legal settings given the minimal requirement of resources and training.This trial is registered with www.clinicaltrials.gov-NCT02938403.

Keywords: adherence; criminal legal; nicotine replacement therapy (NRT); smoking; tobacco.

Conflict of interest statement

MC has received consulting honoraria from Pfizer. PH is on the scientific advisory board of Bright Minds Biosciences Ltd., Eleusis Benefit Corporation, and Reset Pharmaceuticals Inc. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Copyright © 2022 Hawes, Mildrum Chana, Faust, Baker, Hendricks, Azuero, Lahti, Carpenter and Cropsey.

Figures

Figure 1
Figure 1
Study flow chart.

References

    1. US Preventive Services Task Force . Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons: US Preventive Services Task Force Recommendation Statement. JAMA. (2021) 325:265–79. 10.1001/jama.2020.25019
    1. Cornelius ME. Tobacco Product Use Among Adults—United States, 2019. MMWR Morb Mortal Wkly Rep. (2020) 69:1736–42. 10.15585/mmwr.mm6946a4
    1. Winkelman TNA, Vickery KD, Busch AM. Tobacco use among non-elderly adults with and without criminal justice involvement in the past year: United States, 2008–2016. Addict Sci Clin Pract. (2019) 14:2. 10.1186/s13722-019-0131-y
    1. Ahalt C, Buisker T, Myers J, Williams B. Smoking and smoking cessation among criminal justice-involved older adults. Tob Use Insights. (2019) 12:1179173X19833357. 10.1177/1179173X19833357
    1. Spaulding AC, Eldridge GD, Chico CE, Morisseau N, Drobeniuc A, Fils-Aime R, et al. . Smoking in correctional settings worldwide: prevalence, bans, and interventions. Epidemiol Rev. (2018) 40:82–95. 10.1093/epirev/mxy005
    1. Kennedy SM, Sharapova SR, Beasley DD, Hsia J. Cigarette smoking among inmates by race/ethnicity: impact of excluding african american young adult men from national prevalence estimates. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2016) 18:S73–8. 10.1093/ntr/ntv157
    1. Vaughn MG, DeLisi M, Beaver KM, Perron BE, Abdon A. Toward a criminal justice epidemiology: Behavioral and physical health of probationers and parolees in the United States. J Crim Justice. (2012) 40:165–73. 10.1016/j.jcrimjus.2012.03.001
    1. Binswanger IA, Carson EA, Krueger PM, Mueller SR, Steiner JF, Sabol WJ. Prison tobacco control policies and deaths from smoking in United States prisons: population based retrospective analysis. The BMJ. (2014) 349:g4542. 10.1136/bmj.g4542
    1. Andrade D, de Kinner SA. Systematic review of health and behavioural outcomes of smoking cessation interventions in prisons. Tob Control. (2017) 26:495–501. 10.1136/tobaccocontrol-2016-053297
    1. Cropsey K, Eldridge G, Weaver M, Villalobos G, Stitzer M, Best A. Smoking Cessation Intervention for Female Prisoners: Addressing an Urgent Public Health Need. Am J Public Health. (2008) 98:1894–901. 10.2105/AJPH.2007.128207
    1. Kauffman RM, Ferketich AK, Wewers ME. Tobacco policy in American prisons, 2007. Tob Control. (2008) 17:357–60. 10.1136/tc.2007.024448
    1. Frank MR, Blumhagen R, Weitzenkamp D, Mueller SR, Beaty B, Min S-J, et al. . Tobacco use among people who have been in prison: relapse and factors associated with trying to quit. J Smok Cessat. (2017) 12:76–85. 10.1017/jsc.2016.3
    1. Parker DR, Fallone D, Martin RA, Stein LAR, Bock B, Martin SA, et al. . The relation between smoking status and medical conditions among incarcerated adults. J Addict Med. (2014) 8:90–5. 10.1097/ADM.0b013e3182a96466
    1. Minton TD. Correctional Populations in the United States, 2019—Statistical Tables. Stat Tables. (2019) 15:1–15.
    1. Eldridge GD, Cropsey KL. Smoking Bans and Restrictions in U.S. Prisons and Jails: Consequences for Incarcerated Women. Am J Prev Med. (2009) 37:S179–80. 10.1016/j.amepre.2009.05.009
    1. Cropsey KL, Jones-Whaley S, Jackson DO, Hale GJ. Smoking characteristics of community corrections clients. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2010) 12:53–8. 10.1093/ntr/ntp172
    1. O'Connell DJ, Visher CA, Becker P. Linking individuals on probation to health care: a pilot randomized trial. Health Justice. (2020) 8:8. 10.1186/s40352-020-00110-w
    1. Valera P, Acuna N, Vento I. The Preliminary Efficacy and Feasibility of Group-Based Smoking Cessation Treatment Program for Incarcerated Smokers. Am J Mens Health. (2020) 14:1557988320943357. 10.1177/1557988320943357
    1. Cropsey KL, Eldridge GD, Weaver MF, Villalobos GC, Stitzer ML. Expired carbon monoxide levels in self-reported smokers and nonsmokers in prison. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2006) 8:653–9. 10.1080/14622200600789684
    1. Puljević C, Segan CJ. Systematic review of factors influencing smoking following release from smoke-free prisons. Nicotine Tob Res. (2019) 21:1011–20. 10.1093/ntr/nty088
    1. Reaves B, Cohen T. Pretrial release of felony defendants in state courts. (2007) 18:1–18.
    1. Garver-Apgar C, Young S, Howard B, Udochi B, Morris C. Effects of a statewide tobacco cessation program among individuals involved with Arkansas community correction. J Correct Health Care Off J Natl Comm Correct Health Care. (2017) 23:259–70. 10.1177/1078345817709017
    1. Cropsey KL, Clark CB, Stevens EN, Schiavon S, Lahti AC, Hendricks PS. Predictors of medication adherence and smoking cessation among smokers under community corrections supervision. Addict Behav. (2017) 65:111–7. 10.1016/j.addbeh.2016.10.010
    1. Cropsey KL, Clark CB, Zhang X, Hendricks PS, Jardin BF, Lahti AC. Race and medication adherence moderate cessation outcomes in criminal justice smokers. Am J Prev Med. (2015) 49:335–44. 10.1016/j.amepre.2015.03.014
    1. Shiffman S, Sweeney CT, Ferguson SG, Sembower MA, Gitchell JG. Relationship between adherence to daily nicotine patch use and treatment efficacy: secondary analysis of a 10-week randomized, double-blind, placebo-controlled clinical trial simulating over-the-counter use in adult smokers. Clin Ther. (2008) 30:1852–8. 10.1016/j.clinthera.2008.09.016
    1. Panel TU DG . Treating Tobacco Use and Dependence: 2008 Update. Washington, DC: US Department of Health and Human Services; (2008).
    1. Raupach T, Brown J, Herbec A, Brose L, West R, A. systematic review of studies assessing the association between adherence to smoking cessation medication and treatment success. Addict Abingdon Engl. (2014) 109:35–43. 10.1111/add.12319
    1. Pieh-Holder KL, Callahan C, Young P. Qualitative needs assessment: healthcare experiences of underserved populations in Montgomery County, Virginia, USA. Rural Remote Health. (2012) 12:1816. 10.22605/RRH1816
    1. Sewell K, Andreae S, Luke E, Safford MM. Perceptions of and barriers to use of generic medications in a rural African American population, Alabama, 2011. Prev Chronic Dis. (2012) 9:E142. 10.5888/pcd9.120010
    1. Roebuck MC, Liberman JN, Gemmill-Toyama M, Brennan TA. Medication adherence leads to lower health care use and costs despite increased drug spending. Health Aff Proj Hope. (2011) 30:91–9. 10.1377/hlthaff.2009.1087
    1. Kiortsis DN, Giral P, Bruckert E, Turpin G. Factors associated with low compliance with lipid-lowering drugs in hyperlipidemic patients. J Clin Pharm Ther. (2000) 25:445–51. 10.1046/j.1365-2710.2000.00315.x
    1. Cutler DM, Everett W. Thinking Outside the Pillbox — Medication Adherence as a Priority for Health Care Reform. N Engl J Med. (2010) 362:1553–5. 10.1056/NEJMp1002305
    1. Simeonova E. Doctors, patients and the racial mortality gap. J Health Econ. (2013) 32:895–908. 10.1016/j.jhealeco.2013.07.002
    1. Armstrong JD, Bauman A, Moroney KJ, Clark CB. Assessment Treatment of Addictions in Community Corrections. London, UK: IntechOpen; (2021). Available from:
    1. Centers for Disease Control and Prevention (CDC) . Quitting smoking among adults—United States, 2001–2010. MMWR Morb Mortal Wkly Rep. (2011) 60:1513–9.
    1. Balmford J, Borland R, Hammond D, Cummings KM. Adherence to and reasons for premature discontinuation from stop-smoking medications: data from the ITC Four-Country Survey. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2011) 13:94–102. 10.1093/ntr/ntq215
    1. Juliano LM, Brandon TH. Smokers' expectancies for nicotine replacement therapy vs. cigarettes Nicotine Tob Res Off J Soc Res Nicotine Tob. (2004) 6:569–74. 10.1080/14622200410001696574
    1. Mooney ME, Leventhal AM, Hatsukami DK. Attitudes and knowledge about nicotine and nicotine replacement therapy. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2006) 8:435–46. 10.1080/14622200600670397
    1. Ferguson SG, Gitchell JG, Shiffman S, Sembower MA, Rohay JM, Allen J. Providing accurate safety information may increase a smoker's willingness to use nicotine replacement therapy as part of a quit attempt. Addict Behav. (2011) 36:713–6. 10.1016/j.addbeh.2011.02.002
    1. Hollands GJ, McDermott MS, Lindson-Hawley N, Vogt F, Farley A, Aveyard P. Interventions to increase adherence to medications for tobacco dependence. Cochrane Database Syst Rev. (2015) CD009164. 10.1002/14651858.CD009164.pub2
    1. Carpenter MJ, Hughes JR, Gray KM, Wahlquist AE, Saladin ME, Alberg AJ. Nicotine therapy sampling to induce quit attempts among smokers unmotivated to quit. Arch Intern Med. (2011) 171:1901–7. 10.1001/archinternmed.2011.492
    1. Jardin BF, Cropsey KL, Wahlquist AE, Gray KM, Silvestri GA, Cummings KM, et al. . Evaluating the effect of access to free medication to quit smoking: a clinical trial testing the role of motivation. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2014) 16:992–9. 10.1093/ntr/ntu025
    1. Schneider NG, Koury MA, Cortner C, Olmstead RE, Hartman N, Kleinman L, et al. . Preferences among four combination nicotine treatments. Psychopharmacology (Berl). (2006) 187:476–85. 10.1007/s00213-006-0449-5
    1. Schneider NG, Cortner C, Justice M, Gould JL, Amor C, Hartman N, et al. . Preferences among five nicotine treatments based on information versus sampling. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2008) 10:179–86. 10.1080/14622200701767837
    1. Craske MG, Treanor M, Conway CC, Zbozinek T, Vervliet B. Maximizing exposure therapy: An inhibitory learning approach. Behav Res Ther. (2014) 58:10–23. 10.1016/j.brat.2014.04.006
    1. Valera P, Boyas JF, Bernal C, Chiongbian VB, Chang Y, Shelton RC, et al. . Validation of the group-based medical mistrust scale in formerly incarcerated black and Latino men. Am J Mens Health. (2018) 12:844–50. 10.1177/1557988316645152
    1. Benkert R, Cuevas A, Thompson HS, Dove-Medows E, Knuckles D. Ubiquitous Yet Unclear: A Systematic Review of Medical Mistrust. Behav Med. (2019) 45:86–101. 10.1080/08964289.2019.1588220
    1. Cropsey KL, Hendricks PS, Schiavon S, Sellers A, Froelich M, Shelton RC, et al. . A pilot trial of In vivo NRT sampling to increase medication adherence in community corrections smokers. Addict Behav. (2017) 67:92–9. 10.1016/j.addbeh.2016.12.011
    1. Practitioners TRAC of General . Optimising nicotine replacement therapy in clinical practice. Australian Family Physician. East Melbourne, Victoria: The Royal Australian College of general Practitioners (2022). Available from:
    1. Sweeney CT, Fant RV, Fagerstrom KO, McGovern JF, Henningfield JE. Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability. CNS Drugs. (2001) 15:453–67. 10.2165/00023210-200115060-00004
    1. Ebbert JO, Hays JT, Hurt RD. Combination Pharmacotherapy for Stopping Smoking. Drugs. (2010) 70:643–50. 10.2165/11536100-000000000-00000
    1. Valera P, Malarkey S, Smith N, McLaughlin C. Exploring the role of telehealth: a novel approach to group-based smoking cessation treatment for men incarcerated in a rural state prison. J Telemed Telecare. (2021) 1357633X211034734. 10.1177/1357633X211034734
    1. Hugley MJ, Wolford-Clevenger C, Sisson ML, Nguyen AT, Cropsey KL. Self-initiated gradual smoking reduction among community correction smokers. Addict Behav. (2019) 93:100–3. 10.1016/j.addbeh.2019.01.028
    1. Nahvi S, Adams TR, Ning Y, Zhang C, Arnsten JH. Effect of varenicline directly observed therapy versus varenicline self-administered therapy on varenicline adherence and smoking cessation in methadone-maintained smokers: a randomized controlled trial. Addiction. (2021) 116:902–13. 10.1111/add.15240
    1. Tuck BM, Karelitz JL, Tomko RL, Dahne J, Cato P, McClure EA. Mobile, remote, and individual focused: comparing breath carbon monoxide readings and abstinence between smartphone-enabled and stand-alone monitors. Nicotine Tob Res. (2021) 23:741–7. 10.1093/ntr/ntaa203
    1. Vickerman KA, Carpenter KM, Miles LN, Hsu JM, Watt KA, Brandon TH, et al. . Treatment development, implementation, and participant baseline characteristics: a randomized pilot study of a tailored quitline intervention for individuals who smoke and vape. Contemp Clin Trials Commun. (2021) 24:100845. 10.1016/j.conctc.2021.100845
    1. Groenwold RH, Donders AR, Roes KC, Harrell FE, Moons KG. Dealing with missing outcomes data in randomized trials with observational studies. Am J Epidemiol. (2012) 175:210–7. 10.1093/aje/kwr302
    1. MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Meth. (2002) 7:83–104. 10.1037/1082-989X.7.1.83
    1. MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. (2007) 58:593–614. 10.1146/annurev.psych.58.110405.085542
    1. Baggett TP, Lebrun-Harris LA., Rigotti NA. Homelessness, cigarette smoking, and desire to quit: results from a US National Study. Addict Abingdon Engl. (2013) 108:2009–18. 10.1111/add.12292
    1. Rigotti NA, Munafo MR, Stead LF. Smoking cessation interventions for hospitalized smokers: a systematic review. Arch Intern Med. (2008) 168:1950–60. 10.1001/archinte.168.18.1950
    1. Liberman JN, Lichtenfeld MJ, Galaznik A, Mastey V, Harnett J, Zou KH, et al. . Adherence to varenicline and associated smoking cessation in a community-based patient setting. J Manag Care Pharm JMCP. (2013) 19:125–31. 10.18553/jmcp.2013.19.2.125
    1. Dahne J, Tomko RL, McClure EA, Obeid JS, Carpenter MJ. Remote methods for conducting tobacco-focused clinical trials. Nicotine Tob Res Off J Soc Res Nicotine Tob. (2020) 22:2134–40. 10.1093/ntr/ntaa105
    1. Probst T, Haid B, Schimböck W, Reisinger A, Gasser M, Eichberger-Heckmann H, et al. . Therapeutic interventions in in-person and remote psychotherapy: Survey with psychotherapists and patients experiencing in-person and remote psychotherapy during COVID-19. Clin Psychol Psychother. (2021) 28:988–1000. 10.1002/cpp.2553
    1. Simpson S, Richardson L, Pietrabissa G, Castelnuovo G, Reid C. Videotherapy and therapeutic alliance in the age of COVID-19. Clin Psychol Psychother. (2020) 10.1002/cpp.2521. 10.1002/cpp.2521
    1. Hall SM, Humfleet GL, Muñoz RF, Reus VI, Prochaska JJ, Robbins JA. Using extended cognitive behavioral treatment and medication to treat dependent smokers. Am J Public Health. (2011) 101:2349–56. 10.2105/AJPH.2010.300084
    1. Morrison B, Bowman J. What happens beyond the gate? Findings from the post-release employment study. Pract N Z Correct J. (2017) 5.

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever